Citation: I. Leviev et al., Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations, J LIPID RES, 42(4), 2001, pp. 528-535
Authors:
Boemi, M
Leviev, I
Sirolla, C
Pieri, C
Marra, M
James, RW
Citation: M. Boemi et al., Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protectLDL from oxidation, ATHEROSCLER, 155(1), 2001, pp. 229-235
Citation: I. Leviev et al., The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients, DIABETOLOG, 44(9), 2001, pp. 1177-1183
Citation: I. Leviev et Rw. James, Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations, ART THROM V, 20(2), 2000, pp. 516-521
Authors:
James, RW
Leviev, I
Ruiz, J
Passa, P
Froguel, P
Garin, MCB
Citation: Rw. James et al., Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients, DIABETES, 49(8), 2000, pp. 1390-1393
Citation: Rw. James et al., Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease, CIRCULATION, 101(19), 2000, pp. 2252-2257